Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kara L Norman

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Genes & Development|December 3, 2010
Herpes Simplex Virus is Akt-ing in translational controlKara L Norman, Peter Sarnow
Journal of Virology|October 23, 2009
Modulation of hepatitis C virus RNA abundance and the isoprenoid biosynthesis pathway by microRNA miR-122 involves distinct mechanismsKara L Norman, Peter Sarnow
Cell Research|March 2, 2010
Hepatitis C virus' Achilles' heel--dependence on liver-specific microRNA miR-122Kara L Norman, Peter Sarnow
Drug Discovery Today|June 23, 2005
Not all viruses are bad guys: the case for reovirus in cancer therapyKara L Norman, Patrick W K Lee
RNA (New York, N.Y.)|September 21, 2017
Precursor microRNA-122 inhibits synthesis of <i>Insig1</i> isoform mRNA by modulating polyadenylation site usageKara L Norman, Tzu-Chun Chen, Gusti Zeiner, et al.
Nature Reviews. Microbiology|August 17, 2006
MicroRNAs: expression, avoidance and subversion by vertebrate virusesPeter Sarnow, Catherine L Jopling, Kara L Norman, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 21, 2004
Reovirus oncolysis: the Ras/RalGEF/p38 pathway dictates host cell permissiveness to reovirus infectionKara L Norman, Kensuke Hirasawa, An-Dao Yang, et al.
Plos One|January 22, 2010
Toxoplasma gondii infection specifically increases the levels of key host microRNAsGusti M Zeiner, Kara L Norman, J Michael Thomson, et al.
Cancer Research|March 26, 2002
Oncolytic reovirus against ovarian and colon cancerKensuke Hirasawa, Sandra G Nishikawa, Kara L Norman, et al.
Journal of Clinical Pathology|July 22, 2018
Results of the UK NEQAS for Molecular Genetics reference sample analysisSusan D Richman, Jennifer Fairley, Jacqueline A Hall, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Genes & Development|December 3, 2010
Herpes Simplex Virus is Akt-ing in translational controlKara L Norman, Peter Sarnow
Journal of Virology|October 23, 2009
Modulation of hepatitis C virus RNA abundance and the isoprenoid biosynthesis pathway by microRNA miR-122 involves distinct mechanismsKara L Norman, Peter Sarnow
Cell Research|March 2, 2010
Hepatitis C virus' Achilles' heel--dependence on liver-specific microRNA miR-122Kara L Norman, Peter Sarnow
Drug Discovery Today|June 23, 2005
Not all viruses are bad guys: the case for reovirus in cancer therapyKara L Norman, Patrick W K Lee
RNA (New York, N.Y.)|September 21, 2017
Precursor microRNA-122 inhibits synthesis of <i>Insig1</i> isoform mRNA by modulating polyadenylation site usageKara L Norman, Tzu-Chun Chen, Gusti Zeiner, et al.
Nature Reviews. Microbiology|August 17, 2006
MicroRNAs: expression, avoidance and subversion by vertebrate virusesPeter Sarnow, Catherine L Jopling, Kara L Norman, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 21, 2004
Reovirus oncolysis: the Ras/RalGEF/p38 pathway dictates host cell permissiveness to reovirus infectionKara L Norman, Kensuke Hirasawa, An-Dao Yang, et al.
Plos One|January 22, 2010
Toxoplasma gondii infection specifically increases the levels of key host microRNAsGusti M Zeiner, Kara L Norman, J Michael Thomson, et al.
Cancer Research|March 26, 2002
Oncolytic reovirus against ovarian and colon cancerKensuke Hirasawa, Sandra G Nishikawa, Kara L Norman, et al.
Journal of Clinical Pathology|July 22, 2018
Results of the UK NEQAS for Molecular Genetics reference sample analysisSusan D Richman, Jennifer Fairley, Jacqueline A Hall, et al.
Pageof 2